Indo US Bio-Tech (INDOUS) | Stock Overview & Key Data
Indo US Bio-Tech Performance Comparison
Stock Range
Today's Range
Low: ₹142.10
High: ₹145.40
on September 18, 2025
52 Week Range
Low: ₹138.13
High: ₹388.40
on May 9, 2025
on December 10, 2024
All-Time High: ₹388.40 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.9B
EPS
8.91
P/E Ratio (TTM)
16.15
Forward P/E
N/A
P/B Ratio
3.63
PEG Ratio
N/A
Div. Yield
0.16%
ROE
20.72%
Beta
-0.654
Debt to Equity
18.90
Financial Highlights
Profitability
Gross Margin
28.10%
Operating Margin
17.13%
Profit Margin
16.20%
Returns and Earnings
Return on Assets (TTM)
16.63%
Return on Equity (TTM)
20.72%
EBITDA
INR208.2M
Net Income (TTM)
INR178.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR54.80
Quarterly Revenue Growth (YoY)
24.50%
Quarterly Earnings Growth (YoY)
48.40%
Dividend Information
Last 12-Month Dividend
₹0.25
Current Dividend Yield
0.16%
3-Year Average Dividend Yield
0.09%
3-Year Average Annual Dividend
₹0.08
3-Year Total Dividends
₹0.25
Ex-Dividend Date
December 3, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Indo US Bio-Tech INDOUS | 2.90B Small-cap | -3.50% | -8.95% | -5.58% | -8.14% | -52.18% | -51.11% | -51.11% | -51.11% |
| Coromandel COROMANDEL | 671.90B Large-cap | 4.90% | -3.38% | 0.85% | 23.22% | 20.67% | 40.28% | 130.80% | 194.78% |
| UPL UPLPP | 620.31B Large-cap | 0.00% | 0.00% | 22.03% | 96.43% | 129.00% | 104.96% | 104.96% | 104.96% |
| National Fertilizers NFL | 48.76B Small-cap | 1.45% | 9.68% | -0.91% | 31.20% | -16.59% | -22.43% | 101.44% | 205.26% |
| NACL Industries NACLIND | 46.86B Small-cap | -5.02% | -5.58% | 37.12% | 119.22% | 261.93% | 337.05% | 225.96% | 532.81% |
| Bharat Rasayan BHARATRAS | 42.17B Small-cap | -1.03% | -7.29% | -3.01% | 0.78% | -0.20% | -15.15% | -11.80% | 11.24% |
Ownership & Short Interest
Insider Ownership
76.95%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
16K
Average 90-Day Volume
26K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INDOUS's 52-week high and low?
- In the last 52 weeks, Indo US Bio-Tech reached a high of ₹388.40 (on December 10, 2024) and a low of ₹138.13 (on May 9, 2025).
- What is the market cap and P/E ratio for INDOUS?
- Curious about Indo US Bio-Tech's size and valuation? Its market capitalization stands at 2.90B. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.15, and the forward P/E (looking ahead) is N/A.
- Does INDOUS pay dividends? If so, what's the yield?
- Yes, Indo US Bio-Tech is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.16%, and the company has paid an average of ₹0.08 per share annually over the past 3 years.
- Who are Indo US Bio-Tech's main competitors or similar companies to consider before investing?
When looking at Indo US Bio-Tech, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Coromandel
COROMANDEL671.90B Basic Materials Agricultural Inputs 40.28% 130.80% UPL
UPLPP620.31B Basic Materials Agricultural Inputs 104.96% 104.96% National Fertilizers
NFL48.76B Basic Materials Agricultural Inputs -22.43% 101.44% NACL Industries
NACLIND46.86B Basic Materials Agricultural Inputs 337.05% 225.96% Bharat Rasayan
BHARATRAS42.17B Basic Materials Agricultural Inputs -15.15% -11.80% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Indo US Bio-Tech Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Indo US Bio-Tech's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.72%, the Debt to Equity ratio from the most recent quarter is 18.90, and its Gross Profit Margin stands at 28.10%.
- What is the recent revenue and earnings growth for INDOUS?
- Looking at Indo US Bio-Tech's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 24.50%, and quarterly earnings saw a YoY growth of 48.40%.
- How much of INDOUS stock is held by insiders and institutions?
- Wondering who owns Indo US Bio-Tech stock? Company insiders (like executives and directors) hold about 76.95% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.